BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33682442)

  • 21. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
    Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WNK1 in the kidney.
    Bahena-Lopez JP; Gamba G; Castañeda-Bueno M
    Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):471-478. PubMed ID: 35894282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
    Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
    Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.
    Wu G; Peng JB
    FEBS Lett; 2013 Jun; 587(12):1717-22. PubMed ID: 23665031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and analysis of pseudohypoaldosteronism type II knock-in mice caused by a nonsense KLHL3 mutation in the Kelch domain.
    Lin CM; Sung CC; Yang SS; Chen YC; Huang SM; Lin SH
    FASEB J; 2022 Jun; 36(6):e22363. PubMed ID: 35621709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
    Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
    Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-specific regulation of L-WNK1 by dietary K.
    Webb TN; Carrisoza-Gaytan R; Montalbetti N; Rued A; Roy A; Socovich AM; Subramanya AR; Satlin LM; Kleyman TR; Carattino MD
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F15-26. PubMed ID: 26662201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.
    Shibata S; Arroyo JP; Castañeda-Bueno M; Puthumana J; Zhang J; Uchida S; Stone KL; Lam TT; Lifton RP
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15556-61. PubMed ID: 25313067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.
    Cornelius RJ; Zhang C; Erspamer KJ; Agbor LN; Sigmund CD; Singer JD; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1006-F1018. PubMed ID: 29897280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
    Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel KLHL3-interacting motif in the C-terminal region of WNK4.
    Wang L; Wu G; Peng JB
    Biochem Biophys Res Commun; 2023 Aug; 670():87-93. PubMed ID: 37285722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
    Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
    Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
    Uchida S
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Molecular Genetics of Gordon Syndrome.
    Mabillard H; Sayer JA
    Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31795491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
    Hadchouel J; Soukaseum C; Büsst C; Zhou XO; Baudrie V; Zürrer T; Cambillau M; Elghozi JL; Lifton RP; Loffing J; Jeunemaitre X
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18109-14. PubMed ID: 20921400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life.
    Etges A; Hellmig N; Walenda G; Haddad BG; Machtens JP; Morosan T; Rump LC; Scholl UI
    Nephron; 2022; 146(4):418-428. PubMed ID: 35093948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling the Distinct Mechanisms by which Disease-Causing Mutations in the Kelch Domain of KLHL3 Disrupt the Interaction with the Acidic Motif of WNK4 through Molecular Dynamics Simulation.
    Wang L; Jiang C; Cai R; Chen XZ; Peng JB
    Biochemistry; 2019 Apr; 58(16):2105-2115. PubMed ID: 30931564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4.
    Rafael C; Soukaseum C; Baudrie V; Frère P; Hadchouel J
    Sci Rep; 2018 Feb; 8(1):3249. PubMed ID: 29459793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
    Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
    Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.